Abstract
Health care-associated pneumonia is a relatively new classification of pneumonia that includes community-dwelling pneumonia patients having contact with the health care system. Current data indicate that health care-associated pneumonia patients present with more severe disease, are more likely to be infected with drug-resistant pathogens, and suffer increased mortality compared with community-acquired pneumonia patients. Guidelines recommend that these patients receive empiric antibiotics similar to those recommended for nosocomial pneumonia; however, it is not currently known if outcomes are improved when health care-associated pneumonia patients are treated with these therapies. In addition, the individual health care-associated pneumonia risk factors are based on limited data and are a poor predictor of patients likely to be infected with drug-resistant pathogens. Many questions remain on how to most appropriately care for this growing group of pneumonia patients. This review is an evidence-based discussion of current health care-associated pneumonia data, the individual health care-associated pneumonia risk factors, and limitations and additional considerations for the health care-associated pneumonia classification system.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 689-697 |
| Number of pages | 9 |
| Journal | American Journal of Medicine |
| Volume | 124 |
| Issue number | 8 |
| DOIs | |
| State | Published - Aug 2011 |
Fingerprint
Keywords
- Guideline-concordant antibiotic therapy
- Multidrug-resistant
- Pneumonia
ASJC Scopus subject areas
- Medicine(all)
Cite this
Health care-associated pneumonia : An evidence-based review. / Attridge, Russell T.; Frei, Chris.
In: American Journal of Medicine, Vol. 124, No. 8, 08.2011, p. 689-697.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Health care-associated pneumonia
T2 - An evidence-based review
AU - Attridge, Russell T.
AU - Frei, Chris
PY - 2011/8
Y1 - 2011/8
N2 - Health care-associated pneumonia is a relatively new classification of pneumonia that includes community-dwelling pneumonia patients having contact with the health care system. Current data indicate that health care-associated pneumonia patients present with more severe disease, are more likely to be infected with drug-resistant pathogens, and suffer increased mortality compared with community-acquired pneumonia patients. Guidelines recommend that these patients receive empiric antibiotics similar to those recommended for nosocomial pneumonia; however, it is not currently known if outcomes are improved when health care-associated pneumonia patients are treated with these therapies. In addition, the individual health care-associated pneumonia risk factors are based on limited data and are a poor predictor of patients likely to be infected with drug-resistant pathogens. Many questions remain on how to most appropriately care for this growing group of pneumonia patients. This review is an evidence-based discussion of current health care-associated pneumonia data, the individual health care-associated pneumonia risk factors, and limitations and additional considerations for the health care-associated pneumonia classification system.
AB - Health care-associated pneumonia is a relatively new classification of pneumonia that includes community-dwelling pneumonia patients having contact with the health care system. Current data indicate that health care-associated pneumonia patients present with more severe disease, are more likely to be infected with drug-resistant pathogens, and suffer increased mortality compared with community-acquired pneumonia patients. Guidelines recommend that these patients receive empiric antibiotics similar to those recommended for nosocomial pneumonia; however, it is not currently known if outcomes are improved when health care-associated pneumonia patients are treated with these therapies. In addition, the individual health care-associated pneumonia risk factors are based on limited data and are a poor predictor of patients likely to be infected with drug-resistant pathogens. Many questions remain on how to most appropriately care for this growing group of pneumonia patients. This review is an evidence-based discussion of current health care-associated pneumonia data, the individual health care-associated pneumonia risk factors, and limitations and additional considerations for the health care-associated pneumonia classification system.
KW - Guideline-concordant antibiotic therapy
KW - Multidrug-resistant
KW - Pneumonia
UR - http://www.scopus.com/inward/record.url?scp=79960841550&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79960841550&partnerID=8YFLogxK
U2 - 10.1016/j.amjmed.2011.01.023
DO - 10.1016/j.amjmed.2011.01.023
M3 - Article
C2 - 21663884
AN - SCOPUS:79960841550
VL - 124
SP - 689
EP - 697
JO - American Journal of Medicine
JF - American Journal of Medicine
SN - 0002-9343
IS - 8
ER -